Found: 11
Select item for more details and to access through your institution.
Comparison of insulin detemir and insulin glargine using a basal-bolus regimen in a randomized, controlled clinical study in patients with type 2 diabetes.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2009, v. 25, n. 6, p. 542, doi. 10.1002/dmrr.989
- By:
- Publication type:
- Article
Impact of baseline characteristics and beta‐cell function on the efficacy and safety of subcutaneous once‐weekly semaglutide: A patient‐level, pooled analysis of the SUSTAIN 1‐5 trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 3, p. 303, doi. 10.1111/dom.13896
- By:
- Publication type:
- Article
Semaglutide as a therapeutic option for elderly patients with type 2 diabetes: Pooled analysis of the SUSTAIN 1‐5 trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 9, p. 2291, doi. 10.1111/dom.13331
- By:
- Publication type:
- Article
Spondylitis: a clue to hypoparathyroidism.
- Published in:
- 1969
- By:
- Publication type:
- journal article
Cerebral gigantism with intermittent fractional hypopituitarism and normal sella turcica.
- Published in:
- 1967
- By:
- Publication type:
- journal article
Diabetes: Clinical Science in Practice.
- Published in:
- Diabetes Spectrum, 1996, v. 9, n. 2, p. 94
- By:
- Publication type:
- Article
Effect of Insulin Degludec Versus Insulin Glargine U100 on Hypoglycemia in Hispanic Patients With Type 2 Diabetes: Results From the SWITCH 2 Trial.
- Published in:
- Clinical Diabetes, 2019, v. 37, n. 1, p. 73, doi. 10.2337/cd18-0016
- By:
- Publication type:
- Article
Insulin Degludec 200 Units/mL Is Associated With Lower Injection Frequency and Improved Patient-Reported Outcomes Compared With Insulin Glargine 100 Units/mL in Patients With Type 2 Diabetes Requiring High-Dose Insulin.
- Published in:
- Clinical Diabetes, 2017, v. 35, n. 2, p. 90, doi. 10.2337/cd15-0058
- By:
- Publication type:
- Article
Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes: The SWITCH 2 Randomized Clinical Trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Intensification of IDegAsp Twice Daily (Adding Insulin Aspart vs. Switching To Basal-Bolus): Exploratory Randomized Trial in Type 2 Diabetes.
- Published in:
- 2017
- By:
- Publication type:
- Report
The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial.
- Published in:
- Diabetes Therapy, 2017, v. 8, n. 1, p. 101, doi. 10.1007/s13300-016-0218-3
- By:
- Publication type:
- Article